Literature DB >> 8655183

Community-based respiratory viral infections in HIV positive patients with lower respiratory tract disease: a prospective bronchoscopic study.

R F Miller1, C Loveday, J Holton, Y Sharvell, G Patel, N S Brink.   

Abstract

OBJECTIVES: To evaluate the contribution of community-based respiratory virus infections to lower respiratory tract disease in HIV-1 infected individuals.
DESIGN: Prospective clinical cohort study.
SETTING: Specialist in-patient unit for HIV and AIDS, University College London Hospitals, London.
SUBJECTS: 44 consecutive HIV-1 antibody positive patients who underwent 47 diagnostic bronchoscopies for evaluation of the symptoms and signs of lower respiratory tract disease. TIME: Winter months of 1994/95. MAIN OUTCOME MEASURES: Detection, in bronchoscopic alveolar lavage fluid, of infection with influenza A and B, respiratory syncytial virus (RSV), parainfluenza 1, 2 and 3 (by immunofluorescence and cell culture) and adenovirus and enteroviruses (by cell culture).
RESULTS: No evidence of influenza, RSV, parainfluenza, adenovirus, or enterovirus infection was detected.
CONCLUSIONS: Despite a marked increase in RSV and influenza B infection in the general population over the winter of 1994-95, respiratory virus infections were not detected in this cohort of HIV infected patients. As the organisms causing lower respiratory tract disease were related to immunosuppression, this study questions the value of routine identification of community-based respiratory viruses in this patient group.

Entities:  

Mesh:

Year:  1996        PMID: 8655183      PMCID: PMC1195583          DOI: 10.1136/sti.72.1.9

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  8 in total

1.  Spirometric impairments in long-term insulators. Relationships to duration of exposure, smoking, and radiographic abnormalities.

Authors:  A Miller; R Lilis; J Godbold; E Chan; X Wu; I J Selikoff
Journal:  Chest       Date:  1994-01       Impact factor: 9.410

2.  Modeling the impact and cost-effectiveness of HIV prevention efforts.

Authors:  J T Rowley; R M Anderson
Journal:  AIDS       Date:  1994-04       Impact factor: 4.177

3.  Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.

Authors:  J F Murray; C P Felton; S M Garay; M S Gottlieb; P C Hopewell; D E Stover; A S Teirstein
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

4.  Occult alveolar haemorrhage in bronchopulmonary Kaposi's sarcoma.

Authors:  L Hughes-Davies; G Kocjan; M F Spittle; R F Miller
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

5.  Influenza in patients with human immunodeficiency virus infection.

Authors:  S Safrin; J D Rush; J Mills
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

6.  Sputum induction for the diagnosis of pulmonary disease in HIV positive patients.

Authors:  R F Miller; G Kocjan; J Buckland; J Holton; A Malin; S J Semple
Journal:  J Infect       Date:  1991-07       Impact factor: 6.072

7.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981.

Authors:  W P Glezen; M Decker; D M Perrotta
Journal:  Am Rev Respir Dis       Date:  1987-09

8.  Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group.

Authors:  J M Wallace; A V Rao; J Glassroth; N I Hansen; M J Rosen; C Arakaki; P A Kvale; L B Reichman; P C Hopewell
Journal:  Am Rev Respir Dis       Date:  1993-12
  8 in total
  2 in total

Review 1.  Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.

Authors:  Emma Rey-Jurado; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

2.  [Human immunodeficiency virus-infected patients with community-acquired pneumonia: implication of respiratory viruses].

Authors:  Rafael Perelló; Asunción Moreno; Marta Camps; Carlos Cervera; Laura Linares; Tomás Pumarola; María Angeles Marcos
Journal:  Enferm Infecc Microbiol Clin       Date:  2008-02       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.